FOXO1 and hematopoietic and lymphoid system neoplasm: Additionally, FoxO1 and FoxO3 are frequently mutated or hyper-upregulated in leukemia, and pharmacological inhibition of FoxO1 dramatically reduces the aberrant growth of leukemia, indicating the fundamental roles of FoxO1 and FoxO3 in blood cancer [52,53].